George Golumbeski

CIK 1586660 · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$353.9K

Companies

6

Total Filings

40

Lifetime Open-Market Net

-$1.73M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ABOS Director 35,500 $2.37 $84.1K $0 2 2026-06-05
STTK Director 54,613 $4.94 $269.8K $199.8K 9 2026-06-02
MURAV Director $0 3 2025-12-05
Sage Therapeutics, Inc. (SAGE) Delisted Director 0 $8.68 $0 $251.6K 16 2025-07-31
CRBP Director $8.19 $0 1 2020-07-08
ENTA Director 0 $11.90 $0 -$2.18M 9 2020-02-28

Recent Filings · Page 4 of 4

40 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-06-06 Sage Therapeutics, Inc. (SAGE) Delisted Grant (A) $0 EDGAR
2019-03-06 ENTA Mixed -$622.2K EDGAR
2019-03-01 ENTA Grant (A) $0 EDGAR
2019-02-13 ENTA Mixed -$844.7K EDGAR
2019-01-24 Sage Therapeutics, Inc. (SAGE) Delisted Grant (A) $0 EDGAR
2018-03-05 ENTA Grant (A) $0 EDGAR
2017-02-21 ENTA Grant (A) $0 EDGAR
2016-02-12 ENTA Grant (A) $0 EDGAR
2015-02-20 ENTA Grant (A) $0 EDGAR
2014-02-11 ENTA Grant (A) $0 EDGAR
Showing 3140 of 40
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.